Drug Development
Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review
by Waguih William IsHak, MD; Ashley Meyer, BS; Luiza Freire,
September 1, 2024
No Comments
by Waguih William IsHak, MD; Ashley Meyer, BS; Luiza Freire,
by Gahan J. Pandina, PhD; Joan Busner, PhD; Lucas Kempf,
Dear Colleagues: Thirty years ago, the Positive and Negative Syndrome
Innov Clin Neurosci. 2017;14(11–12)S1—S20. A Message From the Editor: Dear Colleagues:
by Jagannadha Avasarala, MD, PhD Dr. Avasarala is Associate Professor
Innov Clin Neurosci. 2017;14(1–2)3–23. A MESSAGE FROM THE EDITOR Dear
Dear Colleagues: Welcome to the September-October 2016 issue of Innovations
Dear Colleagues: Welcome to the July–August 2016 issue of Innovations
Dear Colleagues: Welcome to the May–June 2016 issue of Innovations
The latest in neuroscience—sorted and summarized for you Welcome to
